Global Pharmacovigilance and Drug Safety Software Market – Industry Analysis and Forecast (2017-2024) _ by Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software and Fully Integrated Software), by Delivery Mode (On-Premises and On-Demand/Cloud Based), by End User and by Geography

Global Pharmacovigilance and Drug Safety Software Market – Industry Analysis and Forecast (2017-2024) _ by Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software and Fully Integrated Software), by Delivery Mode (On-Premises and On-Demand/Cloud Based), by End User and by Geography

Market Scenario

Global Pharmacovigilance and Drug Safety Software Market is expected to reach USD 210.90 Million by 2024 from USD 138.26 Million in 2016 at CAGR of 5.42% (Detailed analysis of the market CAGR is provided in the report Global Pharmacovigilance and Drug Safety Software Market Drug Safety Software assist organizations to review, classify, create and other pharmacovigilance data is termed as PV software (or Pharmacovigilance software). This software also assist in creation of adverse event reports. Global Pharmacovigilance and Drug Safety Software Market is segmented by functionality, delivery mode, end user, and geography. Functionality segment is classified as adverse event reporting software, drug safety audits software, issue tracking software and fully integrated software. Delivery mode segment is bifurcated as on-premises and on-demand/cloud based. On-demand/cloud based Delivery mode segment is expected to register highest growth during forecast period. Rise in demand for self-driven analytics, lack of upfront capital investments for hardware, extreme capacity flexibility will fuel the on-demand/cloud based Delivery mode segment growth. End user segment is divided as pharma and biotech companies, contract research organizations (CROS), business process outsourcing (BPO) firms and other pharmacovigilance service providers. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. Rising pressure on pharma and biotech makes to produce safe drugs and increasing adoption of related software services by numerous outsourcing firms are trending the overall Global Pharmacovigilance and Drug Safety Software Market. APAC is going to emerge as highest growth region in Pharmacovigilance and Drug Safety Software Market in forecast period followed by North America and Europe. Rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging economies like India and China will fuel the Pharmacovigilance and Drug Safety Software Market in APAC region. Key Highlights: • Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Pharmacovigilance and Drug Safety Software Market analysis and comprehensive segmentation with respect to the functionality, delivery mode, end user, and geography to assist in strategic business planning • Global Pharmacovigilance and Drug Safety Software Market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America and their key regions Research Methodology: The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get the unbiased idea of the market. This exercise was done at the country level to get the fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for Global Pharmacovigilance and Drug Safety Software Market.   Key Players in the Global Pharmacovigilance and Drug Safety Software Market Are: • Umbra Global • United Biosource Corporation • Sparta Systems, Inc • Sarjen Systems Pvt. Ltd • Oracle Corporation. • Online Business Applications, Inc • Ennov • Extedo GMBH. • AB-Cube • Max Application • Relsys • ArisGlobal • Umbra Global LLC Key Target Audience: • Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • Pharmacovigilance and Drug Safety Software providers • Contract research organizations (CROs) • Government Bodies The scope of the Global Pharmacovigilance and Drug Safety Software Market Report: Research report categorizes the Global Pharmacovigilance and Drug Safety Software Market based on functionality, Delivery mode, end user, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Pharmacovigilance and Drug Safety Software Market with key developments in companies and market trends.

Global Pharmacovigilance and Drug Safety Software Market, By Functionality:

• Adverse Event Reporting Software • Drug Safety Audits Software • Issue Tracking Software • Fully Integrated Software

Global Pharmacovigilance and Drug Safety Software Market, By Delivery Model:

• On-Premises • On-Demand/Cloud Based

Global Pharmacovigilance and Drug Safety Software Market, By End-User:

• Pharma and Biotech Companies • Contract Research Organizations (CROS) • Business Process Outsourcing (BPO) Firms • Other Pharmacovigilance Service Providers

Global Pharmacovigilance and Drug Safety Software Market, By Geography:

• North America • Europe • Asia Pacific • Middle East & Africa • Latin America Available Customization: Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.

Table of Contents

Global Pharmacovigilance and Drug Safety Software Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Pharmacovigilance and Drug Safety Software Market, by Market Value (US$ Bn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. End-User Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast 6.1. Global Pharmacovigilance and Drug Safety Software Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Product 7.4. Global Pharmacovigilance and Drug Safety Software Market Size (US$ Bn) Forecast, by Product 7.5. Global Pharmacovigilance and Drug Safety Software Market Analysis, by Product 7.6. Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis, by Product 8. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, by Delivery Mode 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Mode 8.4. Global Pharmacovigilance and Drug Safety Software Market Size (US$ Bn) Forecast, by Delivery Mode 8.5. Global Pharmacovigilance and Drug Safety Software Market Analysis, by Delivery Mode 8.6. Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis, by Delivery Mode 9. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, by End-User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 9.4. Global Pharmacovigilance and Drug Safety Software Market Size (US$ Bn) Forecast, by End-User 9.5. Global Pharmacovigilance and Drug Safety Software Market Analysis, by End-User 9.6. Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis, by End-User 10. Global Pharmacovigilance and Drug Safety Software Market Analysis, by Region 10.1. Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Region 10.2. Global Pharmacovigilance and Drug Safety Software Market Size (US$ Bn) Forecast, by Region 10.3. Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis, by Region 11. North America Pharmacovigilance and Drug Safety Software Market Analysis 11.1. Key Findings 11.2. North America Pharmacovigilance and Drug Safety Software Market Overview 11.3. North America Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Product 11.4. North America Pharmacovigilance and Drug Safety Software Market Forecast, by Product 11.4.1. Adverse Event Reporting Software 11.4.2. Drug Safety Audits Software 11.4.3. Issue Tracking Software 11.4.4. Fully Integrated Software 11.5. North America Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Mode 11.6. North America Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 11.6.1. On-Premises 11.6.2. On-Demand/Cloud Based 11.7. North America Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 11.8. North America Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.8.1. Pharma and Biotech Companies 11.8.2. Contract Research Organizations (CROS) 11.8.3. Business Process Outsourcing (BPO) Firms 11.8.4. Other Pharmacovigilance Service Providers 11.9. North America Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 11.10. North America Pharmacovigilance and Drug Safety Software Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Pharmacovigilance and Drug Safety Software Market Analysis, by Country 11.12. U.S. Pharmacovigilance and Drug Safety Software Market Forecast, by Product 11.12.1. Adverse Event Reporting Software 11.12.2. Drug Safety Audits Software 11.12.3. Issue Tracking Software 11.12.4. Fully Integrated Software 11.13. U.S. Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 11.13.1. On-Premises 11.13.2. On-Demand/Cloud Based 11.14. U.S. Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.14.1. Pharma and Biotech Companies 11.14.2. Contract Research Organizations (CROS) 11.14.3. Business Process Outsourcing (BPO) Firms 11.14.4. Other Pharmacovigilance Service Providers 11.15. Canada Pharmacovigilance and Drug Safety Software Market Forecast, by Product 11.15.1. Adverse Event Reporting Software 11.15.2. Drug Safety Audits Software 11.15.3. Issue Tracking Software 11.15.4. Fully Integrated Software 11.16. Canada Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 11.16.1. On-Premises 11.16.2. On-Demand/Cloud Based 11.17. Canada Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.17.1. Pharma and Biotech Companies 11.17.2. Contract Research Organizations (CROS) 11.17.3. Business Process Outsourcing (BPO) Firms 11.17.4. Other Pharmacovigilance Service Providers 11.18. North America Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 11.18.1. By Product 11.18.2. By Delivery Mode 11.18.3. By End-User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Pharmacovigilance and Drug Safety Software Market Analysis 12.1. Key Findings 12.2. Europe Pharmacovigilance and Drug Safety Software Market Overview 12.3. Europe Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Product 12.4. Europe Pharmacovigilance and Drug Safety Software Market Forecast, by Product 12.4.1. Adverse Event Reporting Software 12.4.2. Drug Safety Audits Software 12.4.3. Issue Tracking Software 12.4.4. Fully Integrated Software 12.5. Europe Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Mode 12.6. Europe Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 12.6.1. On-Premises 12.6.2. On-Demand/Cloud Based 12.7. Europe Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 12.8. Europe Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.8.1. Pharma and Biotech Companies 12.8.2. Contract Research Organizations (CROS) 12.8.3. Business Process Outsourcing (BPO) Firms 12.8.4. Other Pharmacovigilance Service Providers 12.9. Europe Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 12.10. Europe Pharmacovigilance and Drug Safety Software Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Pharmacovigilance and Drug Safety Software Market Analysis, by Country 12.12. Germany Pharmacovigilance and Drug Safety Software Market Forecast, by Product 12.12.1. Adverse Event Reporting Software 12.12.2. Drug Safety Audits Software 12.12.3. Issue Tracking Software 12.12.4. Fully Integrated Software 12.13. Germany Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 12.13.1. On-Premises 12.13.2. On-Demand/Cloud Based 12.14. Germany Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.14.1. Pharma and Biotech Companies 12.14.2. Contract Research Organizations (CROS) 12.14.3. Business Process Outsourcing (BPO) Firms 12.14.4. Other Pharmacovigilance Service Providers 12.15. Other Healthcare InstitutionsU.K. Pharmacovigilance and Drug Safety Software Market Forecast, by Product 12.15.1. Adverse Event Reporting Software 12.15.2. Drug Safety Audits Software 12.15.3. Issue Tracking Software 12.15.4. Fully Integrated Software 12.16. U.K. Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 12.16.1. On-Premises 12.16.2. On-Demand/Cloud Based 12.17. U.K. Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.17.1. Pharma and Biotech Companies 12.17.2. Contract Research Organizations (CROS) 12.17.3. Business Process Outsourcing (BPO) Firms 12.17.4. Other Pharmacovigilance Service Providers 12.18. France Pharmacovigilance and Drug Safety Software Market Forecast, by Product 12.18.1. Adverse Event Reporting Software 12.18.2. Drug Safety Audits Software 12.18.3. Issue Tracking Software 12.18.4. Fully Integrated Software 12.19. France Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 12.19.1. On-Premises 12.19.2. On-Demand/Cloud Based 12.20. France Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.20.1. Pharma and Biotech Companies 12.20.2. Contract Research Organizations (CROS) 12.20.3. Business Process Outsourcing (BPO) Firms 12.20.4. Other Pharmacovigilance Service Providers 12.21. Italy Pharmacovigilance and Drug Safety Software Market Forecast, by Product 12.21.1. Adverse Event Reporting Software 12.21.2. Drug Safety Audits Software 12.21.3. Issue Tracking Software 12.21.4. Fully Integrated Software 12.22. Italy Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 12.22.1. On-Premises 12.22.2. On-Demand/Cloud Based 12.23. Italy Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.23.1. Pharma and Biotech Companies 12.23.2. Contract Research Organizations (CROS) 12.23.3. Business Process Outsourcing (BPO) Firms 12.23.4. Other Pharmacovigilance Service Providers 12.24. Spain Pharmacovigilance and Drug Safety Software Market Forecast, by Product 12.24.1. Adverse Event Reporting Software 12.24.2. Drug Safety Audits Software 12.24.3. Issue Tracking Software 12.24.4. Fully Integrated Software 12.25. Spain Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 12.25.1. On-Premises 12.25.2. On-Demand/Cloud Based 12.26. Spain Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.26.1. Pharma and Biotech Companies 12.26.2. Contract Research Organizations (CROS) 12.26.3. Business Process Outsourcing (BPO) Firms 12.26.4. Other Pharmacovigilance Service Providers 12.27. Rest of Europe Pharmacovigilance and Drug Safety Software Market Forecast, by Product 12.27.1. Adverse Event Reporting Software 12.27.2. Drug Safety Audits Software 12.27.3. Issue Tracking Software 12.27.4. Fully Integrated Software 12.28. Rest of Europe Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 12.28.1. On-Premises 12.28.2. On-Demand/Cloud Based 12.29. Rest of Europe Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.29.1. Pharma and Biotech Companies 12.29.2. Contract Research Organizations (CROS) 12.29.3. Business Process Outsourcing (BPO) Firms 12.29.4. Other Pharmacovigilance Service Providers 12.30. Europe Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 12.30.1. By Product 12.30.2. By Delivery Mode 12.30.3. By End-User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis 13.1. Key Findings 13.2. Asia Pacific Pharmacovigilance and Drug Safety Software Market Overview 13.3. Asia Pacific Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Product 13.4. Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast, by Product 13.4.1. Adverse Event Reporting Software 13.4.2. Drug Safety Audits Software 13.4.3. Issue Tracking Software 13.4.4. Fully Integrated Software 13.5. Asia Pacific Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Mode 13.6. Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 13.6.1. On-Premises 13.6.2. On-Demand/Cloud Based 13.7. Asia Pacific Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 13.8. Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.8.1. Pharma and Biotech Companies 13.8.2. Contract Research Organizations (CROS) 13.8.3. Business Process Outsourcing (BPO) Firms 13.8.4. Other Pharmacovigilance Service Providers 13.9. Asia Pacific Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 13.10. Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis, by Country 13.12. China Pharmacovigilance and Drug Safety Software Market Forecast, by Product 13.12.1. Adverse Event Reporting Software 13.12.2. Drug Safety Audits Software 13.12.3. Issue Tracking Software 13.12.4. Fully Integrated Software 13.13. China Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 13.13.1. On-Premises 13.13.2. On-Demand/Cloud Based 13.14. China Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.14.1. Pharma and Biotech Companies 13.14.2. Contract Research Organizations (CROS) 13.14.3. Business Process Outsourcing (BPO) Firms 13.14.4. Other Pharmacovigilance Service Providers 13.15. India Pharmacovigilance and Drug Safety Software Market Forecast, by Product 13.15.1. Adverse Event Reporting Software 13.15.2. Drug Safety Audits Software 13.15.3. Issue Tracking Software 13.15.4. Fully Integrated Software 13.16. India Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 13.16.1. On-Premises 13.16.2. On-Demand/Cloud Based 13.17. India Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.17.1. Pharma and Biotech Companies 13.17.2. Contract Research Organizations (CROS) 13.17.3. Business Process Outsourcing (BPO) Firms 13.17.4. Other Pharmacovigilance Service Providers 13.18. Japan Pharmacovigilance and Drug Safety Software Market Forecast, by Product 13.18.1. Adverse Event Reporting Software 13.18.2. Drug Safety Audits Software 13.18.3. Issue Tracking Software 13.18.4. Fully Integrated Software 13.19. Japan Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 13.19.1. On-Premises 13.19.2. On-Demand/Cloud Based 13.20. Japan Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.20.1. Pharma and Biotech Companies 13.20.2. Contract Research Organizations (CROS) 13.20.3. Business Process Outsourcing (BPO) Firms 13.20.4. Other Pharmacovigilance Service Providers 13.21. ASEAN Pharmacovigilance and Drug Safety Software Market Forecast, by Product 13.21.1. Adverse Event Reporting Software 13.21.2. Drug Safety Audits Software 13.21.3. Issue Tracking Software 13.21.4. Fully Integrated Software 13.22. ASEAN Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 13.22.1. On-Premises 13.22.2. On-Demand/Cloud Based 13.23. ASEAN Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.23.1. Pharma and Biotech Companies 13.23.2. Contract Research Organizations (CROS) 13.23.3. Business Process Outsourcing (BPO) Firms 13.23.4. Other Pharmacovigilance Service Providers 13.24. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast, by Product 13.24.1. Adverse Event Reporting Software 13.24.2. Drug Safety Audits Software 13.24.3. Issue Tracking Software 13.24.4. Fully Integrated Software 13.25. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 13.25.1. On-Premises 13.25.2. On-Demand/Cloud Based 13.26. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.26.1. Pharma and Biotech Companies 13.26.2. Contract Research Organizations (CROS) 13.26.3. Business Process Outsourcing (BPO) Firms 13.26.4. Other Pharmacovigilance Service Providers 13.27. Asia Pacific Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 13.27.1. By Product 13.27.2. By Delivery Mode 13.27.3. By End-User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Overview 14.3. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Product 14.4. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Forecast, by Product 14.4.1. Adverse Event Reporting Software 14.4.2. Drug Safety Audits Software 14.4.3. Issue Tracking Software 14.4.4. Fully Integrated Software 14.5. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Mode 14.6. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 14.6.1. On-Premises 14.6.2. On-Demand/Cloud Based 14.7. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 14.8. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 14.8.1. Pharma and Biotech Companies 14.8.2. Contract Research Organizations (CROS) 14.8.3. Business Process Outsourcing (BPO) Firms 14.8.4. Other Pharmacovigilance Service Providers 14.9. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 14.10. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Analysis, by Country 14.12. GCC Pharmacovigilance and Drug Safety Software Market Forecast, by Product 14.12.1. Adverse Event Reporting Software 14.12.2. Drug Safety Audits Software 14.12.3. Issue Tracking Software 14.12.4. Fully Integrated Software 14.13. GCC Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 14.13.1. On-Premises 14.13.2. On-Demand/Cloud Based 14.14. GCC Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 14.14.1. Pharma and Biotech Companies 14.14.2. Contract Research Organizations (CROS) 14.14.3. Business Process Outsourcing (BPO) Firms 14.14.4. Other Pharmacovigilance Service Providers 14.15. South Africa Pharmacovigilance and Drug Safety Software Market Forecast, by Product 14.15.1. Adverse Event Reporting Software 14.15.2. Drug Safety Audits Software 14.15.3. Issue Tracking Software 14.15.4. Fully Integrated Software 14.16. South Africa Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 14.16.1. On-Premises 14.16.2. On-Demand/Cloud Based 14.17. South Africa Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 14.17.1. Pharma and Biotech Companies 14.17.2. Contract Research Organizations (CROS) 14.17.3. Business Process Outsourcing (BPO) Firms 14.17.4. Other Pharmacovigilance Service Providers 14.18. Rest of Middle East & Africa Pharmacovigilance and Drug Safety Software Market Forecast, by Product 14.18.1. Adverse Event Reporting Software 14.18.2. Drug Safety Audits Software 14.18.3. Issue Tracking Software 14.18.4. Fully Integrated Software 14.19. Rest of Middle East & Africa Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 14.19.1. On-Premises 14.19.2. On-Demand/Cloud Based 14.20. Rest of Middle East & Africa Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 14.20.1. Pharma and Biotech Companies 14.20.2. Contract Research Organizations (CROS) 14.20.3. Business Process Outsourcing (BPO) Firms 14.20.4. Other Pharmacovigilance Service Providers 14.21. Middle East & Africa Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By Delivery Mode 14.21.3. By End-User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Pharmacovigilance and Drug Safety Software Market Analysis 15.1. Key Findings 15.2. South America Pharmacovigilance and Drug Safety Software Market Overview 15.3. South America Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Product 15.4. South America Pharmacovigilance and Drug Safety Software Market Forecast, by Product 15.4.1. Adverse Event Reporting Software 15.4.2. Drug Safety Audits Software 15.4.3. Issue Tracking Software 15.4.4. Fully Integrated Software 15.5. South America Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Mode 15.6. South America Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 15.6.1. On-Premises 15.6.2. On-Demand/Cloud Based 15.7. South America Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 15.8. South America Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 15.8.1. Pharma and Biotech Companies 15.8.2. Contract Research Organizations (CROS) 15.8.3. Business Process Outsourcing (BPO) Firms 15.8.4. Other Pharmacovigilance Service Providers 15.9. South America Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 15.10. South America Pharmacovigilance and Drug Safety Software Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Pharmacovigilance and Drug Safety Software Market Analysis, by Country 15.12. Brazil Pharmacovigilance and Drug Safety Software Market Forecast, by Product 15.12.1. Adverse Event Reporting Software 15.12.2. Drug Safety Audits Software 15.12.3. Issue Tracking Software 15.12.4. Fully Integrated Software 15.13. Brazil Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 15.13.1. On-Premises 15.13.2. On-Demand/Cloud Based 15.14. Brazil Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 15.14.1. Pharma and Biotech Companies 15.14.2. Contract Research Organizations (CROS) 15.14.3. Business Process Outsourcing (BPO) Firms 15.14.4. Other Pharmacovigilance Service Providers 15.15. Mexico Pharmacovigilance and Drug Safety Software Market Forecast, by Product 15.15.1. Adverse Event Reporting Software 15.15.2. Drug Safety Audits Software 15.15.3. Issue Tracking Software 15.15.4. Fully Integrated Software 15.16. Mexico Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 15.16.1. On-Premises 15.16.2. On-Demand/Cloud Based 15.17. Mexico Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 15.17.1. Pharma and Biotech Companies 15.17.2. Contract Research Organizations (CROS) 15.17.3. Business Process Outsourcing (BPO) Firms 15.17.4. Other Pharmacovigilance Service Providers 15.18. Rest of South America Pharmacovigilance and Drug Safety Software Market Forecast, by Product 15.18.1. Adverse Event Reporting Software 15.18.2. Drug Safety Audits Software 15.18.3. Issue Tracking Software 15.18.4. Fully Integrated Software 15.19. Rest of South America Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Mode 15.19.1. On-Premises 15.19.2. On-Demand/Cloud Based 15.20. Rest of South America Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 15.20.1. Pharma and Biotech Companies 15.20.2. Contract Research Organizations (CROS) 15.20.3. Business Process Outsourcing (BPO) Firms 15.20.4. Other Pharmacovigilance Service Providers 15.21. South America Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 15.21.1. By Product 15.21.2. By Delivery Mode 15.21.3. By End-User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Umbra Global 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Deployments Footprints 16.3.2. United Biosource Corporation 16.3.3. Sparta Systems, Inc 16.3.4. Sarjen Systems Pvt. Ltd 16.3.5. Oracle Corporation. 16.3.6. Online Business Applications, Inc 16.3.7. Ennov 16.3.8. Extedo GMBH. 16.3.9. AB-Cube 16.3.10. Max Application 16.3.11. Relsys 16.3.12. ArisGlobal 16.3.13. Umbra Global LLC 17. Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID6345
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now